IRIS
GENNARI, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.542
EU - Europa 9.803
AS - Asia 7.140
SA - Sud America 1.426
AF - Africa 234
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 13
Totale 33.189
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.341
CN - Cina 2.424
SG - Singapore 2.302
RU - Federazione Russa 2.082
GB - Regno Unito 1.682
IE - Irlanda 1.517
BR - Brasile 1.201
IT - Italia 1.081
UA - Ucraina 890
FR - Francia 687
VN - Vietnam 670
SE - Svezia 663
HK - Hong Kong 560
DE - Germania 525
KR - Corea 378
FI - Finlandia 342
IN - India 169
BD - Bangladesh 139
CA - Canada 105
ZA - Sudafrica 97
TR - Turchia 96
AR - Argentina 86
IQ - Iraq 67
NL - Olanda 62
ES - Italia 46
MX - Messico 46
PL - Polonia 44
ID - Indonesia 41
PK - Pakistan 39
JP - Giappone 34
CL - Cile 33
EC - Ecuador 32
NG - Nigeria 31
CZ - Repubblica Ceca 29
BE - Belgio 28
CO - Colombia 26
SA - Arabia Saudita 25
AT - Austria 24
UZ - Uzbekistan 24
KE - Kenya 22
AU - Australia 21
NP - Nepal 20
CI - Costa d'Avorio 19
LT - Lituania 18
VE - Venezuela 16
MY - Malesia 14
AE - Emirati Arabi Uniti 13
DZ - Algeria 13
JO - Giordania 13
MA - Marocco 13
IR - Iran 12
JM - Giamaica 12
TN - Tunisia 12
EU - Europa 11
GR - Grecia 11
PE - Perù 11
DK - Danimarca 10
IL - Israele 10
PH - Filippine 10
SY - Repubblica araba siriana 10
EG - Egitto 9
HU - Ungheria 9
PY - Paraguay 9
UY - Uruguay 9
AZ - Azerbaigian 8
DO - Repubblica Dominicana 8
ET - Etiopia 7
KZ - Kazakistan 7
NZ - Nuova Zelanda 7
OM - Oman 7
TH - Thailandia 7
GE - Georgia 6
HN - Honduras 6
KG - Kirghizistan 6
LV - Lettonia 6
TT - Trinidad e Tobago 6
CH - Svizzera 5
RS - Serbia 5
AM - Armenia 4
CR - Costa Rica 4
HR - Croazia 4
IM - Isola di Man 4
KH - Cambogia 4
PT - Portogallo 4
RO - Romania 4
AL - Albania 3
BB - Barbados 3
BH - Bahrain 3
LB - Libano 3
LU - Lussemburgo 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
AO - Angola 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
EE - Estonia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
Totale 33.151
Salva come PNG Salva come JPEG
Città #
Dallas 2.618
Dublin 1.500
Fairfield 1.487
Southend 1.395
Singapore 1.199
Ashburn 1.007
Jacksonville 707
Chandler 702
Woodbridge 660
Santa Clara 653
Wilmington 565
Houston 561
Moscow 545
Hong Kong 539
Seattle 534
Cambridge 527
Beijing 502
Hefei 464
San Jose 391
Seoul 373
Princeton 316
Ann Arbor 305
The Dalles 250
Siena 225
Nanjing 219
Ho Chi Minh City 212
Council Bluffs 194
Lauterbourg 188
Los Angeles 188
Helsinki 157
Hanoi 135
Boardman 106
Buffalo 100
San Diego 98
Shanghai 96
Milan 94
São Paulo 89
Nanchang 86
New York 86
Johannesburg 78
Florence 74
London 73
Dong Ket 72
Izmir 65
Munich 65
San Mateo 62
Rome 60
Shenyang 59
Redondo Beach 52
Tianjin 52
Columbus 50
Dearborn 47
Bengaluru 45
Orem 45
Rio de Janeiro 42
Hebei 41
Belo Horizonte 40
Jiaxing 38
Kunming 37
San Francisco 36
Warsaw 35
Brooklyn 34
Changsha 34
Da Nang 33
Abuja 30
Tokyo 30
Toronto 30
Chicago 29
Frankfurt am Main 29
Montreal 29
Chennai 27
Denver 27
Brussels 26
Düsseldorf 26
Turku 26
Nuremberg 24
Redwood City 24
Brasília 23
Hangzhou 22
Lappeenranta 22
Málaga 22
Norwalk 22
Tashkent 22
Baghdad 21
Manchester 21
Porto Alegre 21
Boston 20
Haiphong 20
Jinan 20
Stockholm 20
Zhengzhou 20
Abidjan 19
Amsterdam 19
Atlanta 19
Falls Church 18
Guangzhou 18
Riyadh 18
Curitiba 17
Dhaka 17
Phoenix 17
Totale 22.157
Salva come PNG Salva come JPEG
Nome #
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) for the treatment of type 2 diabetes mellitus: friends or foes to bone health? a narrative review of clinical studies 1.249
null 398
Activation of the Wnt pathway by small peptides: rational design, synthesis and biological evaluation 328
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes 306
Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study 301
Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone 268
Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women 266
Falls, fractures and vitamin D: a never-ending story? 262
Aromatase activity and bone loss in men 252
Characteristics and familial aggregation of Paget's disease of bone in Italy 249
A non-synonymous TNFRSF11A variation increases NFkB activity and the severity of Paget's disease 247
Bazedoxifene for the prevention of postmenopausal osteoporosis 244
Aromatase activity and bone homeostasis in men 242
Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone. 241
Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease 237
The association of body composition and sexhormones with quantitative ultrasound parameters at the calcaneus and phalanxes in elderly women. 234
Age-related decline of bone mass and intestinal calcium absorption in normal males 234
Dual X-ray absorptiometry and bone ultrasonography in patients with Rett Syndrome 225
ZNF687 Mutations in Severe Paget Disease of Bone Associated with Giant Cell Tumor 224
Undiagnosed vertebral fractures influence quality of life in postmenopausal women with reduced ultrasound parameters. 220
The usefulness of quantitative ultrasound (QUS) measurements in the evaluation of skeletal status in newborns and in children 218
Endocrine actions of osteocalcin 218
Absence of correlation between BMP-4 polymorphism and postmenopausal osteoporosis in Italian women 217
A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. 216
Corretto uso dei marcatori del rimodellamento osseo 215
Aromatase activity and bone loss 214
Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls 210
Bone metabolism in men: role of aromatase activity 208
Vitamin D receptor genotypes and intestinal calcium absorption in postmenopausal women 202
Longitudinal association between sex hormone levels, bone loss and bone turnover in elderly men. 202
Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget’s disease of bone 201
Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women 199
Beyond glycemic control in diabetes mellitus: effects of incretin-based therapy on bone metabolism 199
Appropriate models for novel osteoporosis drug discovery and future perspectives 199
Mutation of PFN1 gene in an early onset, polyostotic Paget-like disease 198
SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone 197
Adiponectin may play a crucial role in the metabolic effects of GLP-1RAs treatment in patients with Type 2 Diabetes Mellitus: a preliminary longitudinal study 193
Mild brachydactyly type A1 maps to chromosome 2q35-q36 and is caused by a novel IHH mutation in a three generation family 192
Lasofoxifene, from the preclinical drug discovery to the treatment of postmenopausal osteoporosis 192
Misdiagnosis of vertebral fractures on local radiographic readings of the multicentre POINT (Prevalence of Osteoporosis in INTernal medicine) study 191
CALCITRIOLO E OSTEOPOROSI 190
Update on the pathogenesis and genetics of Paget's disease of bone 189
The effects of zoledronic acid on serum lipids in multiple myeloma patients 189
Left ventricular hypertrophy differences in male professional runners and in young patients suffering from mild hypertension 188
The impact of infarct size on regional and global left ventricular systolic function: a cardiac magnetic resonance imaging study 187
Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function 187
Effect of electromagnetic fields on bone mineral density and biochemical markers of bone turnover in osteoporosis: a single-blind, randomized, pilot study 186
The combined use of ultrasound and densitometry in the prediction of vertebral fracture 186
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene 185
Vitamin D receptor gene polymorphisms predict acquired resistance to clodronate treatment in patients with Paget's disease of bone 185
Analysis of Usual Consumption of Vitamin D Among Adult Individuals in Italy 184
Aromatase deficiency and male osteoporosis 182
Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease 181
Evidence for increased clinical severity of familial and sporadic Paget’s disease of bone in Campania, southern Italy 180
Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density 180
Effect of electromagnetic fields on bone mineral density and biochemical markers of bone turnover in osteoporosis: a single-blind, randomized pilot study 180
Bona fide genetic associations with bone mineral density 177
Urinary tract infections caused by Gram-negative bacteria in elderly hospitalized patients: epidemiology, clinical features and outcomes in the era of antimicrobial resistance 176
Preventive Role of Vitamin D Supplementation for Acute Phase Reaction after Bisphosphonate Infusion in Paget's Disease 176
Bisphosphonates target B cells to enhance humoral immune responses 175
Pharmacokinetic evaluation of toremifene and its clinical implications for the treatment of osteoporosis 175
Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis 175
Epidemiological, clinical, and genetic characteristics of Paget's disease of bone in a rural area of Calabria, Southern Italy 174
Giant cell tumor occurring in familial Paget's disease of bone: report of clinical characteristics and linkage analysis of a large pedigree 174
Osteoporosis in men: pathophysiology and treatment 173
Diagnosis of Endocrine Disease: Evaluation of bone fragility in endocrine disorders. 173
The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone 172
Quantitative ultrasound and dual-energy X-ray absorptiometry in the prediction of fragility fracture in men 171
Apporto nutrizionale di vitamina D in Italia [Feeding and vitamin D in Italy] 170
The relationship between plasma homocysteine levels and bone mineral density in post-menopausal women 170
Membrane binding sites and non-genomic effects of estrogen in cultured human pre-osteoclastic cells 169
Feasibility of quantitative ultrasound measurements on the humerus of newborn infants for the assessment of the skeletal status. 169
Update on the pharmacogenetics of the vitamin D receptor and osteoporosis 169
Infection by CagA-Positive Helicobacter pylori Strains and Bone Fragility: A Prospective Cohort Study 168
Glucagon-like Peptide-1 Receptor Agonists and Diabetic Osteopathy: Another Positive Effect of Incretines? A 12 Months Longitudinal Study 166
Mechanisms of impaired bone strength in type 1 and 2 diabetes 166
Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk 166
Prevalence of Paget’s disease of bone in Italy 166
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels 165
Polymorphisms of the calcitonin receptor gene are associated with bone mineral density in postmenopausal Italian women 165
Paget's disease of bone: epidemiology, pathogenesis and pharmacotherapy 164
MicroRNAs in bone diseases 164
Quantitative ultrasound and bone mineral density in patients with primary hyperparathyroidism before and after surgical treatment 163
FokI polymorphism at translation initiation site of the vitamin D receptor gene predicts bone mineral density and vertebral fractures in postmenopausal Italian women 163
Idiopathic osteoporosis in men 163
Does calcium supplementation reduce the risk of osteoporotic fracture and bone loss? 162
Lasofoxifene: a third-generation selective estrogen receptor modulator for the prevention and treatment of osteoporosis 160
PTH in the pathogenesis and treatment of glucocorticoid-induced osteoporosis 160
Bone fragility in gastrointestinal disorders 159
Bone fragility in men: where are we? 159
Vitamin D Status in Paget Disease of Bone and Efficacy-Safety Profile of Cholecalciferol Treatment in Pagetic Patients with Hypovitaminosis D. 159
Perspectives in the treatment and prevention of osteoporosis 158
Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis 158
Genome-wide association identifies three new susceptibilityloci for Paget's disease of bone 158
Usefulness of bone quantitative ultrasound in management of osteoporosis in men 157
Lasofoxifene: a new-generation SERM for the treatment of postmenopausal osteoporosis 157
Ospemifene use in postmenopausal women 156
Telomerase repeat amplification protocol (TRAP): A new molecular marker for parathyroid carcinoma 156
Effects of Bisphosphonate Treatment on Circulating Lipid and Glucose Levels in Patients with Metabolic Bone Disorders 155
Dietary Vitamin D Intake in Italian Subjects: Validation of a Frequency Food Questionnaire (FFQ) 154
Totale 20.552
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.535
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.535
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021209 0 0 0 0 0 0 0 0 0 0 0 209
2021/20221.948 124 280 85 202 69 56 87 69 125 226 178 447
2022/20232.674 184 175 355 388 289 584 55 196 270 47 93 38
2023/20242.280 230 76 217 72 52 533 738 44 18 57 46 197
2024/20255.010 105 267 368 238 607 284 170 291 443 278 492 1.467
2025/202611.859 987 1.803 2.249 1.298 1.859 481 1.174 311 399 674 448 176
Totale 33.554